Is Anti-deamidated gliadin (tissue transglutaminase) the same as Anti-deamidated gliadin Immunoglobulin A (IgA) and Immunoglobulin G (IgG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anti-deamidated Gliadin vs. Anti-deamidated Gliadin IgA and IgG

No, anti-deamidated gliadin is not the same as anti-deamidated gliadin IgA and IgG specifically; rather, it refers to antibodies against deamidated gliadin peptides that can be of either IgA or IgG isotype, which are tested separately in clinical practice.

Understanding Deamidated Gliadin Antibodies

  • Deamidated gliadin peptide (DGP) antibodies are serological markers used in celiac disease diagnosis that can be measured as either IgA or IgG isotypes 1
  • These antibodies recognize gliadin peptides that have been modified (deamidated) by the enzyme tissue transglutaminase (tTG), which is the major autoantigen in celiac disease 1
  • When laboratories test for "anti-deamidated gliadin," they are typically measuring either IgA antibodies, IgG antibodies, or both isotypes separately 1

Clinical Testing Approaches

  • In clinical practice, anti-deamidated gliadin antibodies are tested as specific immunoglobulin isotypes:

    • Anti-DGP IgA: Measures immunoglobulin A antibodies against deamidated gliadin peptides 1
    • Anti-DGP IgG: Measures immunoglobulin G antibodies against deamidated gliadin peptides 1
    • Anti-DGP IgA+G: Some assays use a conjugate reactive to both isotypes, giving a positive result if either isotype is present 2
  • The sensitivity and specificity differ between these tests:

    • Anti-DGP IgA: Sensitivity ~74%, specificity ~95% 2
    • Anti-DGP IgG: Sensitivity ~65%, specificity ~98% 2
    • Anti-DGP IgA+G: Sensitivity ~75%, specificity ~94% 2

Clinical Utility and Comparison with Other Celiac Tests

  • Anti-DGP antibodies have reasonably high accuracy for celiac disease diagnosis, although generally considered inferior to tissue transglutaminase (tTG) IgA testing 1
  • Anti-DGP IgG is particularly valuable in IgA-deficient patients, where it shows comparable diagnostic sensitivity to IgG-anti-tTG (88.2% vs. 91.2%) 3
  • The American Gastroenterological Association recommends IgG deamidated gliadin peptides as an option for testing in IgA-deficient patients 1

Important Clinical Considerations

  • Anti-DGP testing should be performed while patients are on a gluten-containing diet to avoid false negative results 1
  • In children under 2 years of age, combining tTG-IgA with IgG and IgA deamidated gliadin peptides is recommended for improved sensitivity 1, 4
  • Studies show good correlation between tTG-IgA and DGP-IgG (r = 0.69), and between tTG-IgA and DGP-IgA (r = 0.67) 5

Clinical Applications

  • Anti-DGP IgG is the preferred test in IgA-deficient patients suspected of having celiac disease 1, 3
  • In standard celiac disease testing, IgA tissue transglutaminase (tTG-IgA) remains the primary recommended screening test 1, 4
  • Some laboratories offer combined detection of IgA/IgG anti-DGP, which may improve sensitivity but can slightly reduce specificity 6

In summary, when referring to "anti-deamidated gliadin," it's important to specify the immunoglobulin isotype (IgA or IgG) as they have different diagnostic characteristics and clinical applications in celiac disease testing.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2008

Guideline

Celiac Disease Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Deamidated gliadin peptide and tissue transglutaminase antibodies in children with coeliac disease: A correlation study.

Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.